T1	Condition 85 89	CAPS
T2	Condition-Name 85 89	CAPS
E1	Condition:T1 Name:T2
T3	Condition 351 377	Sensorineural hearing loss
T4	Condition-Name 351 377	Sensorineural hearing loss
E3	Condition:T3 Name:T4
T5	Condition 420 430	arthralgia
T6	Condition-Name 420 430	arthralgia
E5	Condition:T5 Name:T6
T7	Condition 474 492	aseptic meningitis
T8	Condition-Name 474 492	aseptic meningitis
E7	Condition:T7 Name:T8
T9	Condition 268 287	Urticaria-like rash
T10	Condition-Name 268 287	Urticaria-like rash
E9	Condition:T9 Name:T10
T11	Condition 224 228	CAPS
T12	Condition-Name 224 228	CAPS
E11	Condition:T11 Name:T12 Minimum-Count:E18
T13	Condition 304 308	Cold
T14	Condition-Name 304 308	Cold
E13	Condition:T13 Name:T14
T15	Condition 180 183	SAA
T16	Condition-Name 180 183	SAA
E15	Condition:T15 Name:T16
T17	Drug 719 736	biological agents
T18	Drug-Name 719 736	biological agents
E17	Drug:T17 Name:T18
T19	Eq-Operator 216 217	≥
A1	Eq-Operator-Value T19 GTEQ
T20	Eq-Operator 860 869	less than
A2	Eq-Operator-Value T20 LT
T21	Eq-Temporal-Unit 872 878	months
A3	Eq-Temporal-Unit-Value T21 month
T22	Eq-Value 217 218	2
T23	Eq-Value 222 223	6
T25	Eq-Value 870 871	6
T26	Eq-Comparison 216 218	≥2
E18	Eq-Comparison:T26 Operator:T19 Value:T22
T27	Eq-Comparison 860 878	less than 6 months
E19	Eq-Comparison:T27 Operator:T20 Temporal-Unit:T21 Value:T25
T28	Condition 99 121	pathogenic mutation(s)
E2	Condition:T28 Name:T29
T29	Condition-Name 99 121	pathogenic mutation(s)
T30	Modifier 125 135	NLRP3 gene
E4	Modifier:T30 Modifies:T29
T31	And 90 93	and
E6	And:T31 Arg:E1 Arg2:E2
T32	Condition 147 174	Raised inflammatory markers
E8	Condition:T32 Name:T33
T33	Condition-Name 147 174	Raised inflammatory markers
T34	Condition 176 179	CRP
E10	Condition:T34 Name:T35
T35	Condition-Name 176 179	CRP
T36	Or 179 180	/
E12	Or:T36 Arg:E10 Arg2:E15
R1	Example-Of Arg1:E10 Arg2:E8	
R2	Example-Of Arg1:E15 Arg2:E8	
T37	Assertion 243 251	symptoms
E14	Assertion:T37 Asserted:E11
A4	Assertion-Type-Value E14 possible
T38	Condition 309 315	stress
E16	Condition:T38 Name:T39
T39	Condition-Name 309 315	stress
T40	Or 308 309	/
E20	Or:T40 Arg:E13 Arg2:E16
T41	Condition 394 409	Musculoskeletal
E21	Condition:T41 Name:T42
T42	Condition-Name 394 409	Musculoskeletal
T43	Assertion 410 418	symptoms
E22	Assertion:T43 Asserted:E21
A5	Assertion-Type-Value E22 possible
T44	Condition 431 440	arthritis
E23	Condition:T44 Name:T45
T45	Condition-Name 431 440	arthritis
T46	Condition 441 448	myalgia
E24	Condition:T46 Name:T47
T47	Condition-Name 441 448	myalgia
T48	Or 430 431	/
E25	Or:T48 Arg:E5 Arg2:E23
T49	Or 440 441	/
E26	Or:T49 Arg:E23 Arg2:E24
R3	Example-Of Arg1:E5 Arg2:E21	
R4	Example-Of Arg1:E23 Arg2:E21	
R5	Example-Of Arg1:E24 Arg2:E21	
T50	Modifier 466 473	Chronic
E27	Modifier:T50 Modifies:E7
T51	Condition 518 531	abnormalities
E28	Condition:T51 Name:T52
T52	Condition-Name 518 531	abnormalities
T53	Modifier 509 517	Skeletal
E29	Modifier:T53 Modifies:T52
T54	Condition 533 554	epiphyseal overgrowth
E30	Condition:T54 Name:T55
T55	Condition-Name 533 554	epiphyseal overgrowth
R6	Example-Of Arg1:E30 Arg2:E28	
T56	Condition 555 570	frontal bossing
E31	Condition:T56 Name:T57
T57	Condition-Name 555 570	frontal bossing
R7	Example-Of Arg1:E31 Arg2:E28	
T58	Or 554 555	/
E32	Or:T58 Arg:E30 Arg2:E31
T24	Eq-Comparison 678 683	Being
E33	Eq-Comparison:T24 Temporal-Period:T59
T59	Eq-Temporal-Period 678 683	Being
A6	Eq-Temporal-Period-Value T59 present
T60	Drug 697 711	IL-1 inhibitor
E34	Drug:T60 Name:T61
T61	Drug-Name 697 711	IL-1 inhibitor
T62	Procedure 684 691	treated
E35	Procedure:T62 Temporality:E33
R8	Using Arg1:E35 Arg2:E34	
T63	Other 713 718	other
E36	Other:T63 Is-Other:E17
T64	Drug 741 759	immunosuppressants
E37	Drug:T64 Name:T65
T65	Drug-Name 741 759	immunosuppressants
T66	Or 737 740	and
E38	Or:T66 Arg:E17 Arg2:E37
T67	Condition 770 778	Pregnant
E39	Condition:T67 Name:T68
T68	Condition-Name 770 778	Pregnant
T69	Condition 783 792	lactating
E40	Condition:T69 Name:T70
T70	Condition-Name 783 792	lactating
T71	Or 779 782	and
E41	Or:T71 Arg:E39 Arg2:E40
T72	Life-Stage-And-Gender 793 798	women
A7	Life-Stage-And-Gender-Type T72 female
R9	If-Then Arg1:T72 Arg2:E40	
T73	Condition 817 839	organ function failure
E42	Condition:T73 Name:T74 Severity:T75
T74	Condition-Name 817 839	organ function failure
T75	Severity 809 816	Serious
A8	Severity-Value T75 severe
T76	Observation 841 859	expected life time
E43	Observation:T76 Name:T77 Eq-Comparison:E19
T77	Observation-Name 841 859	expected life time
